A maker of lawn and garden products, Scotts Miracle-Gro sells fertilizers, grass seed, soils and pest controls under brands like Scotts Turf Builder, Miracle-Gro plant food and Ortho. The company traces back to 1868, when Civil War veteran O.M. Scott began selling weed-free grass seed from his Ohio hardware store, and to 1951, when nurseryman Otto Stern and adman Horace Hagedorn launched Miracle-Gro. The two merged in 1995, and the "Miracle-Gro" name was actually suggested by Hagedorn's first wife, Peggy.
Scotts Miracle-Gro raises full-year adjusted EPS guidance to $4.30-$4.45, up from $4.15-$4.35.
Third quarter net sales were $1.17 billion, up 1% versus prior year.
Show detailsHide details
GAAP diluted EPS from continuing operations was $1.75, down 34%; non-GAAP adjusted diluted EPS was $2.82, up 8%.
Company reaffirms full-year outlook: U.S. Consumer net sales low single-digit growth, adjusted gross margin at least 32%, adjusted EBITDA mid single-digit growth, free cash flow of $275 million.
Net leverage ratio improved to 3.78x, down 0.37x versus last year.
Hagedorn Partnership expressed support for new CEO Nate Baxter, who succeeded Jim Hagedorn.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Scotts Miracle-Gro names Nathan E. Baxter CEO, succeeding James Hagedorn
Nathan E. Baxter was named President & CEO and elected to the Board, effective June 26, 2026.
Show detailsHide details
James Hagedorn, CEO since 2001 and Chairman since 2003, resigned from the Board; Peter Shumlin was elected Chairman.
Baxter's annual base salary is $1,100,000 with a 150% target incentive and a $5,250,000 LTIP target for the upcoming fiscal year.
Baxter will receive a $2,000,000 true-up restricted stock unit grant under the Long Term Incentive Plan.
Hagedorn will receive $17,400,000 (reduced by pension value) over 12 months, plus $500,000 for airplane services and $150,000 for administrative support, under a Separation Agreement.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits
Scotts Miracle-Gro reclassifies Hawthorne as discontinued operations, restating FY2024-25 results.
The company classified its Hawthorne business as held for sale and a discontinued operation for all periods presented in its Q1 FY2026 Form 10-Q.
Show detailsHide details
This 8-K furnishes revised GAAP and non-GAAP financial results for fiscal 2024 and 2025, reflecting Hawthorne as discontinued.
For FY2025, revised GAAP net sales were $3,255.8 million, with net income from continuing operations of $182.1 million and a net loss from discontinued operations of $36.9 million.
For FY2024, revised GAAP net sales were $3,268.4 million, with net income from continuing operations of $27.3 million and a net loss from discontinued operations of $62.2 million.
The filing includes revised segment results and a reconciliation of non-GAAP adjusted EBITDA for the affected periods.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Scotts Miracle-Gro shareholders approve 2.75M share increase to long-term incentive plan
At the January 26, 2026 annual meeting, shareholders approved amending the Long-Term Incentive Plan to add 2,750,000 common shares for future grants.
Show detailsHide details
James Hagedorn, Edith Avilés, Roberto Candelino, and Mark D. Kingdon were elected as directors for terms expiring in 2029.
The advisory vote on named executive officer compensation passed with 39,606,777 votes for and 7,422,471 against.
Shareholders ratified Deloitte & Touche LLP as independent auditor for fiscal year ending September 30, 2026.
New equity award agreement forms for executives and non-employee directors take effect January 30, 2026.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
Scotts Miracle-Gro reports Q1 results, plans Hawthorne sale to Vireo, and authorizes $500M buyback
First quarter ended December 27, 2025: net sales $354.4 million, down 3% from $366.6 million a year earlier.
Show detailsHide details
GAAP net loss from continuing operations was $0.83 per share, improved from a $1.15 loss per share in the prior year; non-GAAP adjusted loss was $0.77 per share, improved from $0.88.
GAAP gross margin rate was 25.0% and non-GAAP adjusted gross margin rate was 25.4%, each up 90 basis points year over year.
Company announced advanced discussions to sell its Hawthorne subsidiary to Vireo Growth, Inc., with closing expected in fiscal Q2; Hawthorne results are now reported as discontinued operations.
Board authorized a share repurchase program of up to $500 million, with repurchases expected to commence in late 2026; fiscal 2026 guidance reaffirmed.
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits